IDV vehicle
693JK423D600001
THE U.S. DEPARTMENT OF TRANSPORTATION (DOT) SUBSTANCE ABUSE AWARENESS AND TESTING OFFICE (SAATO) REQUIRES CONTRACTOR FOR FORENSIC ANALYSIS OF URINE SPECIMENS IN SUPPORT OF ITS DRUG-FREE WORKPLACE PROGRAM FOR FEDERAL EMPLOYEES. THIS FORENSIC TOXICO
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Transportation |
| Office | 693JK4 OST |
| NAICS | 621511 — Medical Laboratories |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $4.5M |
| Start date | Mar 28, 2023 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Jul 22, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 22, 2026 | P00007 | $0 | THE PURPOSE OF THIS ADMINISTRATIVE MODIFICATION IS: IN ACCORDANCE WITH EXECUTIVE ORDER (EO) 14398, THE FOLLOWING FAR CLAUSE, FAR 52.222-90 ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS (APR 2026), IS HEREBY INCORPORATED INTO THIS CONTRACT BY |
| Jun 26, 2026 | P00006 | $0 | THE PURPOSE OF THIS ADMINISTRATIVE MODIFICATION IS TO ENTER THE CONTRACT CEILING ($4,466,047.00) UNDER THE LIMITS TAB IN PRISM. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Jun 12, 2026 | P00005 | $0 | THE PURPOSE OF THIS ADMINISTRATIVE MODIFICATION IS TO CORRECT THE ORIGINATING OFFICE CODE FROM OST M-10 WCF TO OST M-14 WCF WORKFORCE QUALITY HUMAN RESOURCES. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Mar 30, 2026 | P00004 | $0 | EXERCISE OPTION YEAR 3 UNDER IDIQ 693JK423D600001 FOR ALERE TOXICOLOGY SERVICES, INC FOR FORENSIC DRUG TESTING LABORATORY ANALYSIS SERVICES. |
| Sep 22, 2025 | P00003 | $0 | THE PURPOSE OF THIS NO-COST MODIFICATION TO IDIQ 693JK423D600001 FOR LABORATORY ANALYSIS WITH ALERE TOXICOLOGY SERVICES IS TO: - INCLUDE REVISED DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) MANDATORY GUIDELINES FOR FEDERAL WORKPLACE DRUG TESTING PRO |
| Feb 24, 2025 | P00002 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION YEAR 2 OF THE FORENSIC TOXICOLOGY DRUG TESTING LABORATORY (FTDTL) ANALYSIS CONTRACT NO. 693JK423D600001. |
| Mar 22, 2024 | P00001 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION YEAR 1 OF THE ALERE TOXICOLOGY SERVICES, INC CONTRACT 693JK423D600001. |
| Mar 28, 2023 | 0 | $0 | THE U.S. DEPARTMENT OF TRANSPORTATION (DOT) SUBSTANCE ABUSE AWARENESS AND TESTING OFFICE (SAATO) REQUIRES CONTRACTOR FOR FORENSIC ANALYSIS OF URINE SPECIMENS IN SUPPORT OF ITS DRUG-FREE WORKPLACE PROGRAM FOR FEDERAL EMPLOYEES. THIS FORENSIC TOXICO |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| jason bush | Contact | jason.bush@dot.gov 2023664117 | Source | Aug 31, 2022 |
| Rochelle Swain | Contact | Rochelle.swain.ctr@dot.gov 202-366-0566 | Source | Aug 31, 2022 |
| jason bush | Contact | jason.bush@dot.gov 2023664117 | Source | Aug 17, 2022 |
| Rochelle Swain | Contact | Rochelle.swain.ctr@dot.gov 202-366-0566 | Source | Aug 17, 2022 |
| jason bush | Contact | jason.bush@dot.gov 2023664117 | Source | Jul 21, 2022 |
| Rochelle Swain | Contact | Rochelle.swain.ctr@dot.gov 202-366-0566 | Source | Jul 21, 2022 |
| jason bush | Contact | jason.bush@dot.gov 2023664117 | Source | Jul 1, 2022 |
| Rochelle Swain | Contact | Rochelle.swain.ctr@dot.gov 202-366-0566 | Source | Jul 1, 2022 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.